"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Aarti Pharmalabs Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln	Chairman : C V Gogri
Home : Indian Private	Book Value: 203.4396162
BSE Code : 543748	Market Cap: 7846.24
NSE Code : AARTIPHARM	P / E : 30.49

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Type	4Qtr	3Qtr	2Qtr	1Qtr
Net Sales	529.62	470.95	377.29	393.49
Other Income	-2.51	11.94	2.95	2.11
Total Income	527.12	482.88	380.24	395.60
Total Expenditure	386.50	355.96	292.52	309.83
Operating Profit	140.62	126.93	87.72	85.77
Interest	6.29	9.70	5.39	4.25
Gross Profit	134.33	117.22	82.33	81.52
Depreciation	20.83	21.04	18.89	18.29
Tax	14.84	17.51	12.79	11.57
Deferred Tax	9.82	5.15	2.80	4.51
Reported Profit After Tax	88.85	73.52	47.84	47.14

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView